408 related articles for article (PubMed ID: 12239238)
21. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
Chiang N; Arita M; Serhan CN
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):163-77. PubMed ID: 16125378
[TBL] [Abstract][Full Text] [Related]
22. Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration.
Bannenberg G; Moussignac RL; Gronert K; Devchand PR; Schmidt BA; Guilford WJ; Bauman JG; Subramanyam B; Perez HD; Parkinson JF; Serhan CN
Br J Pharmacol; 2004 Sep; 143(1):43-52. PubMed ID: 15302682
[TBL] [Abstract][Full Text] [Related]
23. Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin.
Fiorucci S; Distrutti E; Mencarelli A; Morelli A; Laufor SA; Cirino G; Wallace JL
Br J Pharmacol; 2003 Aug; 139(7):1351-9. PubMed ID: 12890715
[TBL] [Abstract][Full Text] [Related]
24. Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Mediation by alpha v beta 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response.
Stern M; Savill J; Haslett C
Am J Pathol; 1996 Sep; 149(3):911-21. PubMed ID: 8780395
[TBL] [Abstract][Full Text] [Related]
25. Taking insult from injury: lipoxins and lipoxin receptor agonists and phagocytosis of apoptotic cells.
Maderna P; Godson C
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):179-87. PubMed ID: 15978792
[TBL] [Abstract][Full Text] [Related]
26. Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side.
Serhan CN
Arch Immunol Ther Exp (Warsz); 2001; 49(3):177-88. PubMed ID: 11478391
[TBL] [Abstract][Full Text] [Related]
27. Endogenous anti-inflammatory mediators from arachidonate in human neutrophils.
Vachier I; Chanez P; Bonnans C; Godard P; Bousquet J; Chavis C
Biochem Biophys Res Commun; 2002 Jan; 290(1):219-24. PubMed ID: 11779156
[TBL] [Abstract][Full Text] [Related]
28. 15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury.
El Kebir D; József L; Pan W; Wang L; Petasis NA; Serhan CN; Filep JG
Am J Respir Crit Care Med; 2009 Aug; 180(4):311-9. PubMed ID: 19483113
[TBL] [Abstract][Full Text] [Related]
29. Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells.
Nascimento-Silva V; Arruda MA; Barja-Fidalgo C; Villela CG; Fierro IM
Am J Physiol Cell Physiol; 2005 Sep; 289(3):C557-63. PubMed ID: 15901601
[TBL] [Abstract][Full Text] [Related]
30. FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis.
Maderna P; Cottell DC; Toivonen T; Dufton N; Dalli J; Perretti M; Godson C
FASEB J; 2010 Nov; 24(11):4240-9. PubMed ID: 20570963
[TBL] [Abstract][Full Text] [Related]
31. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation.
Clària J; Lee MH; Serhan CN
Mol Med; 1996 Sep; 2(5):583-96. PubMed ID: 8898374
[TBL] [Abstract][Full Text] [Related]
32. Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities.
O'Sullivan TP; Vallin KS; Shah ST; Fakhry J; Maderna P; Scannell M; Sampaio AL; Perretti M; Godson C; Guiry PJ
J Med Chem; 2007 Nov; 50(24):5894-902. PubMed ID: 17960922
[TBL] [Abstract][Full Text] [Related]
33. Lipoxins: resolutionary road.
Maderna P; Godson C
Br J Pharmacol; 2009 Oct; 158(4):947-59. PubMed ID: 19785661
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins.
Petasis NA; Akritopoulou-Zanze I; Fokin VV; Bernasconi G; Keledjian R; Yang R; Uddin J; Nagulapalli KC; Serhan CN
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):301-21. PubMed ID: 16098719
[TBL] [Abstract][Full Text] [Related]
35. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion.
Chiang N; Gronert K; Clish CB; O'Brien JA; Freeman MW; Serhan CN
J Clin Invest; 1999 Aug; 104(3):309-16. PubMed ID: 10430612
[TBL] [Abstract][Full Text] [Related]
36. 15-Epi-LXA
Sekheri M; El Kebir D; Edner N; Filep JG
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7971-7980. PubMed ID: 32205444
[TBL] [Abstract][Full Text] [Related]
37. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics.
Serhan CN; Chiang N
Rheum Dis Clin North Am; 2004 Feb; 30(1):69-95. PubMed ID: 15061569
[TBL] [Abstract][Full Text] [Related]
38. A novel rat lipoxin A4 receptor that is conserved in structure and function.
Chiang N; Takano T; Arita M; Watanabe S; Serhan CN
Br J Pharmacol; 2003 May; 139(1):89-98. PubMed ID: 12746227
[TBL] [Abstract][Full Text] [Related]
39. Inosine monophosphate and aspirin-triggered 15-epi-lipoxin A4 act in concert to regulate neutrophil trafficking: additive actions of two new endogenous anti-inflammatory mediators.
Wada K; Qiu FH; Stahl GL; Serhan CN
J Hematother Stem Cell Res; 2001 Feb; 10(1):75-9. PubMed ID: 11276361
[TBL] [Abstract][Full Text] [Related]
40. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.
Chiang N; Serhan CN; Dahlén SE; Drazen JM; Hay DW; Rovati GE; Shimizu T; Yokomizo T; Brink C
Pharmacol Rev; 2006 Sep; 58(3):463-87. PubMed ID: 16968948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
